in this issue
Regions :: India/Pakistan
Indian Cambrex Plant Receives EU GMP Approval
12:26 PM MST | January 18, 2011 | Vincent Valk
Cambrex's manufacturing facility at Hyderabad, India has received good manufacturing practice (GMP) approval from Danish authorities, allowing the company to speed the export of products made at the site to Europe. The site produces nicotine replacement therapy lozenges and chewing gums, and other pharmaceutical products. The Danish GMP approval certificate is recognized by other EU countries, as well, Cambrex says. "This commercially important and significant milestone for Cambrex confirms our commitment to quality in every aspect of operations management...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee